A novel and oral histone deacetylase inhibitor, resminostat, effectively suppresses the growth of non-small cell lung cancer in a xenograft mouse model

被引：1
|
作者：
Takagi, Akimitsu [1 ]
Konishi, Hiroaki [1 ]
Tsugane, Momomi [1 ]
Taniguchi, Keisuke [1 ]
Takahashi, Hiroyuki [2 ]
Inutake, Yu [2 ]
Watanabe, Akinobu [2 ]
Kodaira, Hiroshi [2 ]
Matsuzaki, Takeshi [1 ]
机构：
[1] Yakult Honsha Co Ltd, Yakult Cent Inst Microbiol Res, Tokyo, Japan
[2] Yakult Honsha Co Ltd, Pharmaceut Res & Dev Dept, Tokyo, Japan
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-5534
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5534
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase Ⅰ trial of an oral subtype-selective histone deacetylase inhibitor, chidamide, in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer
    Xingsheng Hu
    Lin Wang
    Lin Lin
    Xiaohong Han
    Guifang Dou
    Zhiyun Meng
    Yuankai Shi
    ChineseJournalofCancerResearch, 2016, 28 (04) : 444 - 451
  • [22] Comparison of anticancer effects of a novel histone deacetylase (HDAC) inhibitor CG200745 and SAHA in non-small lung cancer cells
    Kim, Hak-Ryul
    Jung, Jae-Wan
    Hwang, Ki-Eun
    Park, Chul
    Jeong, Eun-Taik
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [23] Histone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines
    Zhang, Wei
    Peyton, Michael
    Xie, Yang
    Soh, Junichi
    Minna, John D.
    Gazdar, Adi F.
    Frenkel, Eugene P.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (02) : 161 - 166
  • [24] Histone Deacetylase 6 Inhibition Reveals Metabolic Vulnerabilities in KRAS Non-Small Cell Lung Cancer
    Dowling, C.
    Zhang, H.
    Costelloe, N.
    Nabel, C.
    Vucic, E.
    Papadopoulos, E.
    Wong, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1124 - S1124
  • [25] Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non-Small Cell Lung Cancer
    Shin, Hyun-Seock
    Choi, Juwhan
    Lee, Jinhwan
    Lee, Sung Yong
    CANCER RESEARCH AND TREATMENT, 2022, 54 (02): : 458 - 468
  • [26] A Novel Prodrug of a γ-Glutamylcyclotransferase Inhibitor Suppresses Cancer Cell Proliferation in vitro and Inhibits Tumor Growth in a Xenograft Mouse Model of Prostate Cancer
    Ii, Hiromi
    Yoshiya, Taku
    Nakata, Susumu
    Taniguchi, Keiko
    Hidaka, Koushi
    Tsuda, Shugo
    Mochizuki, Masayoshi
    Nishiuchi, Yuji
    Tsuda, Yuko
    Ito, Kosei
    Kageyama, Susumu
    Yoshiki, Tatsuhiro
    CHEMMEDCHEM, 2018, 13 (02) : 155 - 163
  • [27] Magnolol Induces Apoptosis and Suppresses Immune Evasion in Non-small Cell Lung Cancer Xenograft Models
    Lin, Po-ju
    Kuo, Yu-cheng
    Hu, Po-wei
    Chen, Wei-lung
    Chang, Shih-chieh
    Hsu, Fei-ting
    Wu, Jeng-yuan
    Chen, Jiann-hwa
    ANTICANCER RESEARCH, 2024, 44 (10) : 4327 - 4337
  • [28] A novel PI3K inhibitor iMDK suppresses non-small cell lung Cancer cooperatively with A MEK inhibitor
    Ishida, Naomasa
    Fukazawa, Takuya
    Maeda, Yutaka
    Yamatsuji, Tomoki
    Kato, Katsuya
    Matsumoto, Kenichi
    Shimo, Tsuyoshi
    Takigawa, Nagio
    Whitsett, Jeffrey A.
    Naomoto, Yoshio
    EXPERIMENTAL CELL RESEARCH, 2015, 335 (02) : 197 - 206
  • [29] Aurora A, aurora B and survivin are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung cancer
    Zhang, Xu-Hui
    Rao, Mahadev
    Loprieato, Joseph A.
    Hong, Julie A.
    Zhao, Ming
    Chen, Guo-Zhu
    Humphries, Ashley E.
    Nguyen, Dao M.
    Trepel, Jane B.
    Yu, Xiaodan
    Schrump, David S.
    CANCER BIOLOGY & THERAPY, 2008, 7 (09) : 1390 - 1399
  • [30] Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer
    Reid, T
    Valone, F
    Lipera, W
    Irwin, D
    Paroly, W
    Natale, R
    Sreedharan, S
    Keer, H
    Lum, B
    Scappaticci, F
    Bhatnagar, A
    LUNG CANCER, 2004, 45 (03) : 381 - 386
12345